ARGENT CAPITAL MANAGEMENT LLC
Position in NBIX — Neurocrine Biosciences Inc
CIK 1120926
ST LOUIS, MO
Position in NBIX
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$3,094,394
New position
Shares Held
18,360
first reported quarter
Ownership
0.018%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#262
of 772 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026ARGENT CAPITAL MANAGEMENT LLC holds $43,594,031 across 2 Drug Manufacturers - Specialty & Generic names. NBIX ranks #2 (7.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VTRS |
Viatris Inc
|
2,550,355 | $40,499,637 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
This page
|
18,360 | $3,094,394 |
All Filings in NBIX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,094,394 | 18,360 | Shares | Sole | 2026-07-15 | |
| No filing history on record for this holder in this stock. | ||||||